BioMed Realty Appoints Ankit Patel as Executive Vice President and Chief Financial Officer

Mr. Patel will lead the Company’s financial reporting, accounting, financial planning and analysis, tax, treasury, capital markets, information technology and asset management functions, reporting to BioMed Realty CEO Tim Schoen.

San Diego, CA (November 21, 2022) – BioMed Realty, a leading provider of real estate solutions to the life science and technology industries, announced today that Ankit Patel will join the company as Executive Vice President and Chief Financial Officer, effective November 28, 2022.

In this role, Mr. Patel will lead the Company’s financial reporting, accounting, financial planning and analysis, tax, treasury, capital markets, information technology and asset management functions, reporting to Tim Schoen, CEO of BioMed Realty, and will be based in BioMed Realty’s San Diego headquarters.

“We are thrilled to welcome Ankit to BioMed Realty where he will serve as a strong pillar on our executive team,” Mr. Schoen said. “Ankit’s impressive experience in the healthcare real estate industry will lend itself seamlessly to supporting the work we do here at BioMed Realty to provide life science and technology companies with real estate solutions.”
“I am excited to join the incredibly talented team at BioMed, an excellent company that I have long admired,” Mr. Patel said. “I feel honored to have the opportunity to work alongside them as they continue to support their current and future tenants, which include some of the world’s most innovative organizations.”

Mr. Patel joins BioMed Realty with over 13 years of experience in the healthcare and life science real estate sectors gained from leading the financial and strategic planning functions, capital markets and external reporting at Ventas, a large diversified healthcare REIT and S&P 500 company. Mr. Patel most recently served as the Senior Vice President, Corporate Finance & Capital Markets, and his previous roles involved investor relations, acquisitions, and contributing to the company’s environmental, social, and governance (ESG) efforts. Prior to joining Ventas in 2009, Mr. Patel began his career in investment banking at UBS and management consulting at IBM. He holds a Bachelor of Engineering degree from the University of Michigan and a Master of Business Administration degree from the University of Chicago Booth School of Business.

In recognition of his financial leadership and impact within the community, Mr. Patel was featured on the 2022 Crain’s Chicago Business list of Notable Executives of Color in Construction and Commercial Real Estate. Mr. Patel has also served as a member of the Board of EverThrive, a nonprofit organization that champions health equity and advocates for access to high-quality healthcare for women, children and families.

Mr. Patel succeeds John Lu, who is transitioning from the company to pursue other opportunities outside of real estate after six years as BioMed Realty’s Executive Vice President and Chief Financial Officer.

“On behalf of everyone at BioMed, I want to thank John Lu for his tremendous dedication and exceptional service to our company during a period of extraordinary growth,” Schoen said. “We appreciate all of his many contributions to the success of the company and wish him the best of luck in his future endeavors.”

More News

Kendall Square

Press Release

BioMed Realty’s Sustainability Report Emphasizes Long-Term Commitment to Sustainable, Innovative Environments as Recognized by GRESB

This year’s Sustainability Report highlights BioMed Realty’s progress to advance long-term energy efficiency and sustainability across its 17-million-square-foot global operating portfolio.

Press Release

BioMed Realty joins Global Arts Live and Takeda in Announcing The Platform at 585 Kendall

The Platform at 585 Kendall addresses a documented need for a midsized professional theater that benefits the broader Cambridge arts community.

Press Release

BioMed Realty, Blackstone Real Estate and MIT Leaders Celebrate Groundbreaking of Biogen’s New Global Headquarters

The state-of-the-art facility will consolidate Biogen’s operations and strengthen its nearly five-decade legacy of advancing breakthrough medicines.

Search BioMed